Study of CD4+CD8+ double positive T-lymphocyte phenotype and function in Indian patients infected with HIV-1. 2012

Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

CD4+CD8+ double positive T cells represent a minor peripheral blood lymphocyte population. CD4+ expression on CD8+ T cells is induced following cellular activation, and as chronic HIV-1 infection is associated with generalized immune activation, double positive T cells studies have become necessary to understand the immunopathology of human immunodeficiency virus (HIV). The frequency of double positive T cells in persons infected with HIV was studied in comparison to uninfected controls. Further, the expression of CD38, HLA-DR, and programmed death (PD)-1 on these cells were ascertained. HIV-1 specific double positive T cells were also studied for their cytokine secretory ability and phenotype. A significantly higher double positive cell population was observed in the patients with advanced HIV disease (CD4+ T cell counts below 200 cells/µl), as compared to patients with CD4+ T cell counts above 500 cells/µl. Double positive T cells from patients with symptomatic HIV disease had a significantly increased activation and exhaustion levels, compared to asymptomatic subjects and to single positive T cells from the same subjects. HIV-1 specific double positive T cells showed further increase in CD38 and PD-1 expression levels. The proportion of CD38 and PD-1 expressing total and HIV-1 specific double positive T cells correlated positively with HIV-1 plasma viremia and negatively with CD4+ T cell counts. HIV infection results in a marked increase of double positive T cell population, and this cell population shows higher level of activation and exhaustion (increased PD-1 expression) compared to the single positive CD4+ and CD8+ T cells.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
March 2017, International journal of hematology,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
January 1989, Vox sanguinis,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
November 1993, AIDS (London, England),
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
March 2000, Clinical and experimental immunology,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
December 2000, AIDS patient care and STDs,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
June 2006, Clinical immunology (Orlando, Fla.),
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
November 2008, Current HIV research,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
September 2006, The Indian journal of medical research,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
October 2007, Journal of immunological methods,
Neeraj K Chauhan, and Madhu Vajpayee, and Kamalika Mojumdar, and Ravinder Singh, and Alpana Singh
December 1999, Veterinary immunology and immunopathology,
Copied contents to your clipboard!